Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Low Dose of Decitabine Combined With Gemcitabine in First-line Treatment of Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

NCT02685228 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT02685228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02685228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Low Dose of Decitabine Combined With Gemcitabine in First-line Treatment of Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
Lead sponsor
The First Hospital of Jilin University
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2016
Completion date
December 31, 2018
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer